Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for Cementos Bio-Bio's Debt-to-Equity or its related term are showing as below:
XSGO:CEMENTOS'
s Debt-to-Equity Range Over the Past 10 Years
Min: 0.43 Med: 0.5 Max: 0.8
Current: 0.43
During the past 13 years, the highest Debt-to-Equity Ratio of Cementos Bio-Bio was 0.80. The lowest was 0.43. And the median was 0.50.
XSGO:CEMENTOS's Debt-to-Equity is not ranked
in the Building Materials industry.
Industry Median: 0.35
vs XSGO:CEMENTOS: 0.43
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
Cementos Bio-Bio Debt-to-Equity Related Terms
Cementos Bio-Bio Debt-to-Equity Historical Data
* Premium members only.
The historical data trend for Cementos Bio-Bio's Debt-to-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSGO:CEMENTOS vs CRH, VMC, MLM: Debt-to-Equity Comparison
For the Building Materials subindustry, Cementos Bio-Bio's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cementos Bio-Bio Debt-to-Equity vs Building Materials Industry
For the Building Materials industry and Basic Materials sector, Cementos Bio-Bio's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where Cementos Bio-Bio's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cementos Bio-Bio (XSGO:CEMENTOS) has a Debt-to-Equity of 0.43 as of Dec. 2025. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Cementos Bio-Bio and its competitors. This is 14% below median its historical median of 0.50. Over the past decade, Cementos Bio-Bio's Debt-to-Equity has ranged from 0.43 to 0.80.
Is Cementos Bio-Bio's Debt-to-Equity too high?
Cementos Bio-Bio's current Debt-to-Equity of 0.43 is 14% below median its 10-year median of 0.50. Over the past 10 years, this metric has ranged from a low of 0.43 to a high of 0.80. The Building Materials industry median Debt-to-Equity is 0.35. Cementos Bio-Bio's value of 0.43 is 22.9% above this industry median. Overall, Cementos Bio-Bio has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does Cementos Bio-Bio's Debt-to-Equity compare to CRH and VMC?
Cementos Bio-Bio's Debt-to-Equity of 0.43 can be compared against companies in the Building Materials industry. The industry median Debt-to-Equity is 0.35. Cementos Bio-Bio's value of 0.43 is 22.9% above this benchmark. Historically, Cementos Bio-Bio's own Debt-to-Equity has ranged from 0.43 to 0.80 over the past decade. While the company's 10-year median is 0.50 vs. the industry median of 0.35, Cementos Bio-Bio has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Building Materials company?
The median Debt-to-Equity among Building Materials companies is 0.35, based on 370 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cementos Bio-Bio's current Debt-to-Equity of 0.43 is 22.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Cementos Bio-Bio and its competitors. For the Building Materials industry, the median Debt-to-Equity is 0.35 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cementos Bio-Bio's current Debt-to-Equity is 0.43, which is 14% below median its own 10-year median of 0.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cementos Bio-Bio stock overvalued right now?
Cementos Bio-Bio (XSGO:CEMENTOS) has a current Debt-to-Equity of 0.43. The stock's GF Value™ is CLP742.22, compared to a current price of CLP1,730.00 — trading 133.1% above its estimated fair value. The current Debt-to-Equity is 0.43, which is 14% below median its 10-year median of 0.50 and 22.9% above the Building Materials industry median of 0.35. Cementos Bio-Bio's overall GF Score™ is 34/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For Cementos Bio-Bio (XSGO:CEMENTOS), the current Debt-to-Equity is 0.43 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cementos Bio-Bio (XSGO:CEMENTOS) Overvalued in 2026?
Based on GuruFocus' analysis, Cementos Bio-Bio stock appears to be overvalued.
The current stock price of CLP1,730.00 is trading 133.1% above its estimated GF Value™ of CLP742.22.
Key valuation signals for XSGO:CEMENTOS:
Debt-to-Equity: 0.43 (14% below median its 10-year median of 0.50)
GF Value™: CLP742.22 vs. price of CLP1,730.00 (133.1% above fair value)
Industry Position: 22.9% above the Building Materials median
No single metric tells the full story. See the XSGO:CEMENTOS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSGO:CEMENTOS has been successfully added to your 
